MoneyWorks4Me

Laurus Labs informs about board meeting

19 Jan 2021 Evaluate
Laurus Labs has informed that the meeting of the Board of Directors of the Company is scheduled on 28/01/2021 to consider and approve the Un-Audited Financial Results of the Company for the quarter and nine months ended December 31, 2020; and to consider the proposal for payment of 2nd Interim Dividend for FY 2020-21 and fixation of record date for determining the eligibility of shareholders (if approved). 

The above information is a part of company’s filings submitted to BSE.

Laurus Labs Share Price

1814.95 -26.10 (-1.42%)
14-Aug-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma. Inds. 1924.90
Dr. Reddys Labs. 1202.00
Cipla 1450.00
Lupin 2235.00
Zydus Lifesciences 1140.00
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through: